Glycotope Announces New Strategy to Maximize Potential of Uniquely-Tumor Specific Antibody Platform
March 24, 2022 03:00 ET | Glycotope
Glycotope Announces New Strategy to Maximize Potential of Uniquely-Tumor Specific Antibody Platform Expansion of senior team to focus on drug discovery and developmentPlatform combines glycobiology...